An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.

Arjune SenMary AkinolaXin You TaiMkael SymmondsGabriel Davis JonesSergio MuraJoanne GallowayAngela HallamJane Y C ChanIvan KoychevChris ButlerJohn GeddesRohan Van Der PuttSian ThompsonSanjay G ManoharEleni FrangouSharon LoveRupert McShaneMasud Husain

Published in: Trials (2021)

ClinicalTrials.gov NCT03489044 . Registered on April 5, 2018.

Keyphrases

placebo controlled
double blind
phase ii
study protocol
phase iii
clinical trial
phase ii study
cognitive decline
open label
randomized controlled trial
mild cognitive impairment